Skip to content

HEYLEN FARMA: what changed

BE 0444.326.811NACE 47.730, Retail sale of pharmaceutical productsOther company

Position among the sector peers

What moved between 2023 and 2024

Net result for the year
€22,925
2023 · €37,225-€14,300
Equity
€299,410
2023 · €276,485+€22,925
Cash
€175,749
2023 · €112,822+€62,927
Balance sheet total
€826,841
2023 · €592,502+€234,340

Largest movements

2023 to 2024
Assets
  • Tangible fixed assets +€171,190

    up €171,190 (+73.1%), from €234,252 to €405,442

    of which Assets under construction and advance payments: +€178,035

  • Cash +€62,927

    up €62,927 (+55.8%), from €112,822 to €175,749

    mainly Debts after one year (+€222,665) and Depreciation (+€57,888)

  • Receivables within one year +€15,751

    up €15,751 (+13.2%), from €119,775 to €135,525

    of which Trade receivables: +€15,145

  • Stocks and contracts -€12,135

    down €12,135 (-12.6%), from €95,984 to €83,850

Equity and liabilities
  • Debts after one year +€222,665

    up €222,665 (+134%), from €166,543 to €389,207

  • Other debts -€33,751

    down €33,751 (-91.2%), from €37,000 to €3,249

  • Profit (loss) carried forward +€22,925

    up €22,925 (+51.4%), from €44,605 to €67,530

  • Tax, wage and social debts +€20,964

    up €20,964 (+77.6%), from €27,011 to €47,975

    of which Taxes: +€12,298

Income statement
  • Gross operating margin +€71,750

    up €71,750 (+31.5%), from €228,105 to €299,855

  • Depreciation +€42,052

    up €42,052 (+266%), from €15,836 to €57,888

  • Staff costs +€37,490

    up €37,490 (+24.0%), from €156,419 to €193,908

  • Financial charges +€7,990

    up €7,990 (+48.3%), from €16,554 to €24,544

Change in the result, 2023 to 2024

effect on the result

For each income-statement line you see the change as its effect on the result. Higher costs lower the result, higher income raises it.

Result 2023 €37,225
Gross operating margin +€71,750
Staff costs -€37,490
Depreciation -€42,052
Other operating charges +€1,937
Other operating items -€735
Financial income -€416
Financial charges -€7,990
Taxes +€696
Result 2024 €22,925
raises the resultlowers the resultnot broken down further in the accounts

Derived cash bridge

cash 2023 to 2024

The bridge is derived from the 2023 and 2024 balance sheets and the 2024 result. There is no filed cash-flow statement. You see where the money came from and where it went.

From operations +€68,743
Investment -€229,079
Financing +€223,263
Cash 2023 €112,822
Net result for the year +€22,925
Depreciation +€57,888
Stocks and contracts +€12,135
Receivables within one year -€15,751
Deferred charges and accrued income +€3,394
Trade debts -€49
Tax, wage and social debts +€20,964
Other debts -€33,751
Accrued charges and deferred income +€987
Investment in fixed assets (net) -€229,079
Debts after one year +€222,665
Current portion of long-term debt +€598
Cash 2024 €175,749
brings cash intakes cash out
Every line side by side 50 lines
Line Code 2023 2024 Change %
Total assets 20/58 €592,502 €826,841 +€234,340 +39.6%
Fixed assets 21/28 €234,252 €405,442 +€171,190 +73.1%
Tangible fixed assets 22/27 €234,252 €405,442 +€171,190 +73.1%
Land and buildings 22 €208,972 €201,844 -€7,127 -3.4%
Plant, machinery and equipment 23 €2,545 €3,082 +€537 +21.1%
Furniture and vehicles 24 €952 €698 -€254 -26.7%
Assets under construction and advance payments 27 €21,783 €199,818 +€178,035 +817%
Current assets 29/58 €358,250 €421,399 +€63,149 +17.6%
Stocks and contracts in progress 3 €95,984 €83,850 -€12,135 -12.6%
Stocks 30/36 €95,984 €83,850 -€12,135 -12.6%
Amounts receivable within one year 40/41 €119,775 €135,525 +€15,751 +13.2%
Trade receivables 40 €96,559 €111,703 +€15,145 +15.7%
Other amounts receivable 41 €23,216 €23,822 +€606 +2.6%
Cash at bank and in hand 54/58 €112,822 €175,749 +€62,927 +55.8%
Deferred charges and accrued income 490/1 €29,670 €26,275 -€3,394 -11.4%
Total equity and liabilities 10/49 €592,502 €826,841 +€234,340 +39.6%
Equity 10/15 €276,485 €299,410 +€22,925 +8.3%
Contributions 10/11 €210,800 €210,800 = 0.0%
Capital 10 €210,800 €210,800 = 0.0%
Issued capital 100 €210,800 €210,800 = 0.0%
Reserves 13 €21,080 €21,080 = 0.0%
Non-distributable reserves 130/1 €21,080 €21,080 = 0.0%
Legal reserve 130 €21,080 €21,080 = 0.0%
Profit (loss) carried forward 14 €44,605 €67,530 +€22,925 +51.4%
Amounts payable 17/49 €316,017 €527,431 +€211,414 +66.9%
Amounts payable after more than one year 17 €166,543 €389,207 +€222,665 +134%
Financial debts 170/4 €166,543 €389,207 +€222,665 +134%
Amounts payable within one year 42/48 €147,374 €135,136 -€12,238 -8.3%
Current portion of amounts payable after more than one year 42 €15,745 €16,342 +€598 +3.8%
Trade debts 44 €67,619 €67,569 -€49 -0.1%
Suppliers 440/4 €67,619 €67,569 -€49 -0.1%
Taxes, remuneration and social security 45 €27,011 €47,975 +€20,964 +77.6%
Taxes 450/3 €4,055 €16,353 +€12,298 +303%
Remuneration and social security 454/9 €22,956 €31,622 +€8,666 +37.8%
Other amounts payable 47/48 €37,000 €3,249 -€33,751 -91.2%
Accrued charges and deferred income 492/3 €2,101 €3,088 +€987 +47.0%
Remuneration, social security and pensions 62 €156,419 €193,908 +€37,490 +24.0%
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets 630 €15,836 €57,888 +€42,052 +266%
Other operating charges 640/8 €2,580 €643 -€1,937 -75.1%
Non-recurring operating charges 66A - €735 +€735
Gross operating margin 9900 €228,105 €299,855 +€71,750 +31.5%
Operating profit (loss) 9901 €53,270 €46,680 -€6,589 -12.4%
Financial income 75/76B €4,752 €4,336 -€416 -8.7%
Recurring financial income 75 €4,752 €4,336 -€416 -8.7%
Financial charges 65/66B €16,554 €24,544 +€7,990 +48.3%
Recurring financial charges 65 €16,554 €24,544 +€7,990 +48.3%
Profit (loss) for the period before taxes 9903 €41,468 €26,473 -€14,995 -36.2%
Income taxes 67/77 €4,243 €3,547 -€696 -16.4%
Profit (loss) for the period 9904 €37,225 €22,925 -€14,300 -38.4%
Profit (loss) for the period to be appropriated 9905 €37,225 €22,925 -€14,300 -38.4%

Value

latest balance sheet 31-12-2024 · indication, not a valuation or advice

Indicative value of the equity

Indication, not a valuation or advice
€227,341 to €258,395

Midpoint €240,280 · 50% capitalised earnings, 50% adjusted equity

Capitalisation rate 12% result over 3 years, excluding non-recurring income and charges earnings weight 50%

Worked out with Checked's starting values, not your estimate and not market data. Change the assumptions: the value follows.

Adjusted equity €299,410
Capitalised earnings €155,271 to €217,380
Indication €227,341 to €258,395

Adjusted equity

balance sheet 31-12-2024
Equity (10/15)
€299,410
Revaluation of assets
€0
Deferred tax on the revaluation
€0
Other adjustment
€0
Adjusted equity
€299,410

Capitalised earnings

net result for the year (9904)
2024
€22,925
excluding non-recurring income and charges
€23,661
2023
€37,225
2022
€4,104
excluding non-recurring income and charges
€4,327
2021
€100,352
excluding non-recurring income and charges
€98,907
2020
€20,167
Average result, excluding non-recurring income and charges
€21,738
Divided by the capitalisation rate
14% / 12% / 10%
Capitalised earnings
€155,271 / €181,150 / €217,380

Limits of the indication

  • Checked holds no market prices or comparable transactions.
  • Anything after the latest accounts and items off the balance sheet (guarantees, leases, disputes) are left out.
  • Checked does not know the real value of buildings, stock and receivables. Enter your own revaluation or adjustment for it.
  • The result is not corrected for the manager's pay. If the company pays less or more than a market salary, the capitalised earnings are too high or too low.
  • The owner's role in the business, synergies for a buyer and the tax consequences of a sale are left out.

For a valuation to base a decision on, go to a company auditor or a certified accountant.

Calculation and sources

Source: filed annual accounts (NBB) and main activity (KBO). The movements compare the financial years ended 31 December 2023 and 31 December 2024. Green is a favourable move for that line, red an unfavourable one. The value is an indication, not a valuation or advice. Prepared on 15 November 2026 via checked.be.